References
- Anisimova N, Ustyuzhanina N, Bilan M, Donenko F, Usov A, Kiselevskiy M, Nifantiev N. Fucoidan and Fucosylated Chondroitin Sulfate Stimulate Hematopoiesis in Cyclophosphamide-Induced Mice. Mar Drugs. 2017;15:301. PMid:28973980. doi:
https://doi.org/10.3390/md15100301 . - Asimakopoulou AP, Theocharis AD, Tzanakakis GN, Karamanos NK. The biological role of chondroitin sulfate in cancer and chondroitin-based anticancer agents. In Vivo. 2008;22:385–9. PMid:18610752. .
- Bai X, Wang Y, Hu B, Cao Q, Xing M, Song S, Ji A. Fucoidan Induces Apoptosis of HT-29 Cells via the Activation of DR4 and Mitochondrial Pathway. Marine Drugs. 2020;18:220. doi:
https://doi.org/10.3390/md18040220 . - Bittkau KS, Dörschmann P, Blümel M, Tasdemir D, Roider J, Klettner A, Alban S. Comparison of the Effects of Fucoidans on the Cell Viability of Tumor and Non-Tumor Cell Lines. Mar Drugs. 2019;17:441. PMid:31357497. doi:
https://doi.org/10.3390/md17080441 . - Chantree P, Na-Bangchang K, Martviset P. Anticancer Activity of Fucoidan via Apoptosis and Cell Cycle Arrest on Cholangiocarcinoma Cell. Asian Pac J Cancer Prev. 2021;22:209–17. PMid:33507701. doi:
https://doi.org/10.31557/APJCP.2021.22.1.209 . - Duan Y, Li J, Jing X, Ding X, Yu Y, Zhao Q. Fucoidan Induces Apoptosis and Inhibits Proliferation of Hepatocellular Carcinoma via the p38 MAPK/ERK and PI3K/Akt Signal Pathways. Cancer Manag Res. 2020;12:1713–23. PMid:32210612. doi:
https://doi.org/10.2147/CMAR.S243495 . - Edmondson R, Broglie JJ, Adcock AF, Yang L. Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. Assay Drug Dev Technol. 2014;12:207–18. PMid:24831787. doi:
https://doi.org/10.1089/adt.2014.573 . - Hayakawa K, Nagamine T. Effect of Fucoidan on the Biotinidase Kinetics in Human Hepatocellular Carcinoma. Anticancer Research. 2009;29:1211–7. PMid:19414366. .
- Hayes AJ, Melrose J. Neural Tissue Homeostasis and Repair Is Regulated via CS and DS Proteoglycan Motifs. Front Cell Dev Biol. 2021;9:696640. PMid:34409033. doi:
https://doi.org/10.3389/fcell.2021.696640 . - Kapałczyńska M, Kolenda T, Przybyła W, Zajączkowska M, Teresiak A, Filas V, Ibbs M, Bliźniak R, Łuczewski Ł, Lamperska K. 2D and 3D cell cultures – a comparison of different types of cancer cell cultures. Arch Med Sci. 2018;14:910–9. PMid:30002710. doi:
https://doi.org/10.5114/aoms.2016.63743 . - Kim BS, Kang H-J, Park J-Y, Lee J. Fucoidan promotes osteoblast differentiation via JNK- and ERK-dependent BMP2–Smad 1/5/8 signaling in human mesenchymal stem cells. Exp Mol Med. 2015;47:e128–e128. doi:
https://doi.org/10.1038/emm.2014.95 . - Kiselevskiy MV, Anisimova NYu, Ustyuzhanina NE, Vinnitskiy DZ, Tokatly AI, Reshetnikova VV, Chikileva IO, Shubina IZh, Kirgizov KI, Nifantiev NE. Perspectives for the Use of Fucoidans in Clinical Oncology. Int J Mol Sci. 2022;23:11821. PMid:36233121. doi:
https://doi.org/10.3390/ijms231911821 . - Li H, Fan X, Houghton J. Tumor microenvironment: The role of the tumor stroma in cancer. Journal of Cellular Biochemistry. 2007;101:805–15. doi:
https://doi.org/10.1002/jcb.21159 . - Liu S, Yang J, Peng X, Li J, Zhu C. The Natural Product Fucoidan Inhibits Proliferation and Induces Apoptosis of Human Ovarian Cancer Cells: Focus on the PI3K/Akt Signaling Pathway. Cancer Manag Res. 2020;12:6195–207. PMid:32884336. doi:
https://doi.org/10.2147/CMAR.S254784 . - Mehta G, Hsiao AY, Ingram M, Luker GD, Takayama S. Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy. J Control Release. 2012;164:192–204. PMid:22613880. doi:
https://doi.org/10.1016/j.jconrel.2012.04.045 . - Nováková E, Mikušová V, Šupolíková M. Spheroids as 3D Cell Models for Testing of Drugs. European Pharmaceutical Journal. 2023;70:37–43. doi:
https://doi.org/10.2478/afpuc-2023-0008 . - Saliba J, Manseur C, Groult H, Akil H, Tannoury M, Troutaud D, Maugard T, Feuillard J, Arnaudin I, Jayat-Vignoles C. Anti-Proliferative and Pro-Apoptotic vLMW Fucoidan Formulas Decrease PD-L1 Surface Expression in EBV Latency III and DLBCL Tumoral B-Cells by Decreasing Actin Network. Marine Drugs. 2023;21:132. doi:
https://doi.org/10.3390/md21020132 . - Sanjeewa KKA, Herath KHINM, Yang H-W, Choi CS, Jeon Y-J. Anti-Inflammatory Mechanisms of Fucoidans to Treat Inflammatory Diseases: A Review. Mar Drugs. 2021;19:678. PMid:34940677. doi:
https://doi.org/10.3390/md19120678 . - Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671–5. doi:
https://doi.org/10.1038/nmeth.2089 . - Vinci M, Gowan S, Boxall F, Patterson L, Zimmermann M, Court W, Lomas C, Mendiola M, Hardisson D, Eccles SA. Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biology. 2012;10:29. doi:
https://doi.org/10.1186/1741-7007-10-29 . - Zima J, Nováková E, Mikušová V, Šupolíková M. Štúdium liečivých látok na báze glykozaminoglykánov a sulfátovaných heteropolysacharidov s imunomodulačnými vlastnosťami. Bulletin ČSSM. 2022;4:140–51.